Heparin Surface Modified Lenses

The latest development in IOL technology is heparin surface modification of lenses by O.I.I.* This is an important advance in ophthalmic implant technology—and another step into the future of implant surgery by O.I.I.

Heparin is a carbohydrate molecule endogenous to most mammals. It is not recognized as a foreign substance by the body and does not appear to elicit immunologic reactions.

In addition, heparin coating has been tested on various devices for the purpose of reducing bacterial adhesion and thereby reducing the risk of infection. Referred articles in the scientific literature that elaborate on these benefits of heparin coating are available on request.

The patented heparin surface modification of O.I.I. treated lenses provides a strong molecular attachment between the heparin and the polymer lens surface.

Only sterile, medical grade heparin, which is fully tested in accordance with USP specifications, is used in this process, a battery of in vitro/in vivo tests have been performed according to ISO 10993 Tripartite guidelines, all with good results.

Coated in one of O.I.I.'s state-of-the-art clean rooms, these premium lenses are brought to you sterile and ready to implant.

Call for our latest catalog that includes these new products and more!

	HXP-50C	HSP-55B	HSP-65A	HSP-65A2
Q/A Dia.	12.0 mm	12.5 mm	13.0 mm	13.0 mm
Optic Dia.	5.0 mm	5.5 mm	6.5 mm	6.5 mm
Haptic Angle	5°	5°	10°	10°
AC Depth*	4.8	4.8	5.1	5.1
A Constant*	118.0	118.0	118.3	118.3

*Not available for sale or distribution in the United States

Ophthalmic Innovations International, Inc., 500 N. Claremont Blvd., Claremont, CA 91711. Tel: 909-626-4558; Fax: 909-626-7338.